1. Home
  2. CYTK vs AOS Comparison

CYTK vs AOS Comparison

Compare CYTK & AOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$76.84

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo A.O. Smith Corporation

AOS

A.O. Smith Corporation

N/A

Current Price

$63.49

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
AOS
Founded
1997
1874
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.6B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
AOS
Price
$76.84
$63.49
Analyst Decision
Strong Buy
Hold
Analyst Count
19
9
Target Price
$89.26
$75.44
AVG Volume (30 Days)
1.7M
1.7M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
2.26%
EPS Growth
N/A
6.06
EPS
N/A
1.75
Revenue
$13,368,000.00
$3,830,200,000.00
Revenue This Year
$7.37
$4.51
Revenue Next Year
$310.19
$3.80
P/E Ratio
N/A
$35.54
Revenue Growth
N/A
0.32
52 Week Low
$34.60
$54.16
52 Week High
$88.31
$81.87

Technical Indicators

Market Signals
Indicator
CYTK
AOS
Relative Strength Index (RSI) 45.54 57.68
Support Level $73.95 $63.34
Resistance Level $79.66 $63.91
Average True Range (ATR) 2.91 1.93
MACD -0.37 0.21
Stochastic Oscillator 33.77 78.84

Price Performance

Historical Comparison
CYTK
AOS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AOS A.O. Smith Corporation

A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (80% of sales) and rest of world (20% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 36% and 52% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered in the mid-1990s.

Share on Social Networks: